Altimmune, Inc has announced the appointment of Linda M Richardson as Chief Commercial Officer, effective September 16, 2025. With over 30 years of experience, she is set to lead the company’s commercial readiness initiatives.
Company Information
Company
Altimmune
Location
910 Clopper Rd
Gaithersburg, Maryland, United States
About
Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD), Alcohol-associated Liver Disease (ALD) and obesity.
Fundz sees it the moment Altimmune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.